Ost-müük RenovoRx, Inc. - RNXT CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Kauplemistingimused
| Hinnavahe | 0.12 | ||||||||
|
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
|
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
| Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
| Min kauplemise kogus | 1 | ||||||||
| Valuuta | USD | ||||||||
| Tagatis | 20% | ||||||||
| Aktsiabörs | United States of America | ||||||||
| Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Võtmestatistika
| Eelmine sulgemine* | 2 |
| Avatud* | 2.14 |
| Aastane muutus* | 15.05% |
| Päeva ulatus* | 1.98 - 2.14 |
| 52 nädala ulatus | 1.50-5.75 |
| Keskmine maht (10 päeva) | 23.72K |
| Keskmine maht (3 kuud) | 940.90K |
| Turukapitalisatsioon | 21.07M |
| P/E suhtarv | -100.00K |
| Ringluses olevad aktsiad | 10.13M |
| Tulu | N/A |
| EPS | -1.12 |
| Dividendid (% kasumist) | N/A |
| Beeta | -100.00K |
| Järgmine tuluaruande kuupäev | N/A |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
|---|---|---|---|---|---|---|
| Jun 2, 2023 | 2.02 | -0.11 | -5.16% | 2.13 | 2.14 | 1.98 |
| Jun 1, 2023 | 2.00 | -0.03 | -1.48% | 2.03 | 2.10 | 1.88 |
| May 31, 2023 | 1.84 | -0.04 | -2.13% | 1.88 | 1.98 | 1.74 |
| May 30, 2023 | 1.85 | 0.03 | 1.65% | 1.82 | 1.92 | 1.79 |
| May 26, 2023 | 1.88 | 0.05 | 2.73% | 1.83 | 1.89 | 1.82 |
| May 25, 2023 | 1.88 | 0.04 | 2.17% | 1.84 | 1.88 | 1.84 |
| May 24, 2023 | 2.04 | 0.02 | 0.99% | 2.02 | 2.07 | 1.92 |
| May 23, 2023 | 2.00 | 0.14 | 7.53% | 1.86 | 2.03 | 1.86 |
| May 22, 2023 | 2.01 | -0.12 | -5.63% | 2.13 | 2.14 | 1.99 |
| May 19, 2023 | 2.04 | -0.10 | -4.67% | 2.14 | 2.14 | 2.04 |
| May 18, 2023 | 2.13 | 0.05 | 2.40% | 2.08 | 2.16 | 2.08 |
| May 17, 2023 | 2.03 | -0.10 | -4.69% | 2.13 | 2.13 | 1.98 |
| May 16, 2023 | 2.13 | -0.08 | -3.62% | 2.21 | 2.21 | 2.10 |
| May 15, 2023 | 2.19 | 0.06 | 2.82% | 2.13 | 2.24 | 2.11 |
| May 12, 2023 | 1.98 | -0.51 | -20.48% | 2.49 | 2.58 | 1.98 |
| May 11, 2023 | 2.60 | -0.06 | -2.26% | 2.66 | 2.78 | 2.57 |
| May 10, 2023 | 2.73 | 0.14 | 5.41% | 2.59 | 2.73 | 2.59 |
| May 9, 2023 | 2.59 | -0.09 | -3.36% | 2.68 | 2.71 | 2.56 |
| May 8, 2023 | 2.76 | -0.06 | -2.13% | 2.82 | 2.82 | 2.76 |
| May 5, 2023 | 2.75 | -0.15 | -5.17% | 2.90 | 2.90 | 2.75 |
RenovoRx, Inc. Events
| Kellaaeg (UTC) (UTC) | Riik | Sündmus |
|---|---|---|
| Tuesday, June 6, 2023 | ||
| Kellaaeg (UTC) (UTC) 10:59 | Riik US
| Sündmus RenovoRx Inc at LD Micro Invitational Conference RenovoRx Inc at LD Micro Invitational ConferenceForecast -Previous - |
| Thursday, June 8, 2023 | ||
| Kellaaeg (UTC) (UTC) 16:00 | Riik US
| Sündmus RenovoRx Inc Annual Shareholders Meeting RenovoRx Inc Annual Shareholders MeetingForecast -Previous - |
- Aastas
- Kvartalis
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Kogutulu | 0 | 0 | 0 | 0 |
| Kogu tegevuskulu | 9.95 | 5.609 | 3.204 | 3.896 |
| Müük/Üldine/admin kulud, kokku | 5.649 | 2.632 | 0.818 | 0.899 |
| Uuringud ja arendus | 4.301 | 3.039 | 2.386 | 2.997 |
| Tulud majandustegevusest | -9.95 | -5.609 | -3.204 | -3.896 |
| Intressitulud (kulu), muud tulud, neto | 0.057 | -0.834 | -0.587 | 0.063 |
| Muud, neto | 0.004 | 0.119 | -0.007 | -0.006 |
| Netotulu enne makse | -9.889 | -6.324 | -3.798 | -3.839 |
| Netotulu pärast makse | -9.889 | -6.324 | -3.798 | -3.839 |
| Netotulu enne erikulusid | -9.889 | -6.324 | -3.798 | -3.839 |
| Netotulu | -9.889 | -6.324 | -3.798 | -3.839 |
| Arvestatav tulu, v a erikulud | -9.889 | -6.324 | -3.798 | -3.839 |
| Arvestatav tulu, koos erikuludega | -9.889 | -6.324 | -3.798 | -3.839 |
| Jaotamisele kuuluv netotulu | -9.889 | -6.324 | -3.798 | -3.839 |
| Keskmine jaotamisele kuuluv aktsia kohta | 9.05173 | 5.217 | 8.38437 | 8.38437 |
| Jaotatav EPS, v a erakorralised kulud | -1.0925 | -1.21219 | -0.45299 | -0.45788 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
| Jaotamisele kuuluv normaal-EPS | -1.0925 | -1.22408 | -0.45299 | -0.45788 |
| Ootamatud kulutused (tulu) | 0 | -0.062 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Kogutulu | 0 | 0 | 0 | 0 | 0 |
| Kogu tegevuskulu | 3.261 | 2.17 | 2.161 | 2.614 | 3.005 |
| Müük/Üldine/admin kulud, kokku | 1.923 | 1.394 | 1.315 | 1.224 | 1.716 |
| Uuringud ja arendus | 1.338 | 0.776 | 0.846 | 1.39 | 1.289 |
| Ootamatud kulutused (tulu) | 0 | 0 | 0 | 0 | |
| Tulud majandustegevusest | -3.261 | -2.17 | -2.161 | -2.614 | -3.005 |
| Intressitulud (kulu), muud tulud, neto | 0.004 | 0.014 | 0.022 | 0.02 | 0.001 |
| Muud, neto | 0 | 0 | 0.003 | 0 | 0.001 |
| Netotulu enne makse | -3.257 | -2.156 | -2.136 | -2.594 | -3.003 |
| Netotulu pärast makse | -3.257 | -2.156 | -2.136 | -2.594 | -3.003 |
| Netotulu enne erikulusid | -3.257 | -2.156 | -2.136 | -2.594 | -3.003 |
| Netotulu | -3.257 | -2.156 | -2.136 | -2.594 | -3.003 |
| Arvestatav tulu, v a erikulud | -3.257 | -2.156 | -2.136 | -2.594 | -3.003 |
| Arvestatav tulu, koos erikuludega | -3.257 | -2.156 | -2.136 | -2.594 | -3.003 |
| Jaotamisele kuuluv netotulu | -3.257 | -2.156 | -2.136 | -2.594 | -3.003 |
| Keskmine jaotamisele kuuluv aktsia kohta | 9.08999 | 9.08898 | 9.06751 | 9.05719 | 8.9924 |
| Jaotatav EPS, v a erakorralised kulud | -0.35831 | -0.23721 | -0.23557 | -0.2864 | -0.33395 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Jaotamisele kuuluv normaal-EPS | -0.35831 | -0.23721 | -0.23557 | -0.2864 | -0.33395 |
- Aastas
- Kvartalis
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Käibevarad kokku | 7.265 | 16.281 | 1.91 | 2.266 |
| Raha ja lühiajalised investeeringud | 6.44 | 15.192 | 1.795 | 2.104 |
| Raha ja ekvivalendid | 4.391 | 15.192 | 1.795 | 2.104 |
| Prepaid Expenses | 0.825 | 1.089 | 0.115 | 0.142 |
| Other Current Assets, Total | 0 | 0.02 | ||
| Total Assets | 7.265 | 16.287 | 1.914 | 2.27 |
| Other Long Term Assets, Total | 0.004 | 0.004 | ||
| Total Current Liabilities | 1.102 | 0.938 | 4.096 | 0.805 |
| Accounts Payable | 0.534 | 0.525 | 0.162 | 0.538 |
| Accrued Expenses | 0.568 | 0.413 | 0.311 | 0.232 |
| Notes Payable/Short Term Debt | 0 | 0 | 2.65 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 0.117 | 0 | |
| Other Current Liabilities, Total | 0 | 0.856 | 0.035 | |
| Total Liabilities | 1.102 | 0.938 | 4.119 | 0.805 |
| Total Long Term Debt | 0 | 0 | 0.023 | 0 |
| Long Term Debt | 0 | 0.023 | 0 | |
| Total Equity | 6.163 | 15.349 | -2.205 | 1.465 |
| Redeemable Preferred Stock | 0 | 0 | 12.451 | 12.391 |
| Common Stock | 0.001 | 0.001 | 0.001 | 0.001 |
| Additional Paid-In Capital | 37.318 | 36.632 | 0.303 | 0.235 |
| Retained Earnings (Accumulated Deficit) | -31.173 | -21.284 | -14.96 | -11.162 |
| Total Liabilities & Shareholders’ Equity | 7.265 | 16.287 | 1.914 | 2.27 |
| Total Common Shares Outstanding | 9.0977 | 8.93399 | 8.38437 | 8.38437 |
| Property/Plant/Equipment, Total - Net | 0 | 0.006 | ||
| Lühiajalised investeeringud | 2.049 | |||
| Other Equity, Total | 0.017 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 4.561 | 7.265 | 9.25 | 11.243 | 13.943 |
| Raha ja lühiajalised investeeringud | 3.723 | 6.44 | 8.114 | 10.765 | 13.121 |
| Raha ja ekvivalendid | 3.723 | 4.391 | 3.093 | 2.769 | 13.121 |
| Prepaid Expenses | 0.592 | 0.825 | 1.136 | 0.478 | 0.822 |
| Total Assets | 4.561 | 7.265 | 9.25 | 11.243 | 13.946 |
| Other Long Term Assets, Total | |||||
| Total Current Liabilities | 1.305 | 1.102 | 1.102 | 1.123 | 1.406 |
| Accounts Payable | 0.828 | 0.534 | 0.538 | 0.473 | 0.729 |
| Accrued Expenses | 0.477 | 0.568 | 0.564 | 0.65 | 0.677 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | |||||
| Other Current Liabilities, Total | |||||
| Total Liabilities | 1.305 | 1.102 | 1.102 | 1.123 | 1.406 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Long Term Debt | |||||
| Total Equity | 3.256 | 6.163 | 8.148 | 10.12 | 12.54 |
| Redeemable Preferred Stock | 0 | 0 | 0 | ||
| Common Stock | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
| Additional Paid-In Capital | 37.685 | 37.318 | 37.151 | 37.004 | 36.826 |
| Retained Earnings (Accumulated Deficit) | -34.43 | -31.173 | -29.017 | -26.881 | -24.287 |
| Total Liabilities & Shareholders’ Equity | 4.561 | 7.265 | 9.25 | 11.243 | 13.946 |
| Total Common Shares Outstanding | 9.13125 | 9.0977 | 9.07226 | 9.06686 | 9.02931 |
| Property/Plant/Equipment, Total - Net | 0 | 0 | 0 | 0.003 | |
| Lühiajalised investeeringud | 0 | 2.049 | 5.021 | 7.996 | |
| Other Equity, Total | 0 | 0.017 | 0.013 | -0.004 | |
| Other Current Assets, Total | 0.246 |
- Aastas
- Kvartalis
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Netotulu/algväärtus | -9.889 | -6.324 | -3.798 | -3.839 |
| Raha majandustegevusest | -8.811 | -5.916 | -3.528 | -3.35 |
| Mittelikviidsed varad | 0.65 | 0.673 | 0.539 | 0.046 |
| Muutused tööjõus | 0.428 | -0.265 | -0.269 | 0.443 |
| Tulu investeeringutelt | -2.032 | -0.015 | 0 | -0.001 |
| Muud rahavood investeeringutelt, kokku | -2.032 | 0 | -0.001 | |
| Rahavood investeeringutelt | 0.042 | 19.328 | 3.199 | 0 |
| Rahavoogudesse investeerimine | 0 | 0.003 | 0 | |
| Aktsiate emiteerimine (tagasiost), neto | 0.042 | 17.351 | 0.018 | 0 |
| Laenu väljastamine (kustutamine), neto | 0 | 1.977 | 3.178 | 0 |
| Rahaline kogumuutus | -10.801 | 13.397 | -0.329 | -3.351 |
| Kapitalikulutused | 0 | -0.015 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -3.257 | -9.889 | -7.733 | -5.597 | -3.003 |
| Cash From Operating Activities | -2.706 | -8.811 | -7.13 | -4.458 | -2.097 |
| Non-Cash Items | 0.115 | 0.65 | 0.486 | 0.343 | 0.171 |
| Changes in Working Capital | 0.436 | 0.428 | 0.117 | 0.796 | 0.735 |
| Cash From Financing Activities | 0.006 | 0.042 | 0.039 | 0.035 | 0.026 |
| Issuance (Retirement) of Stock, Net | 0.006 | 0.042 | 0.039 | 0.035 | 0.026 |
| Net Change in Cash | -0.668 | -10.801 | -12.099 | -12.423 | -2.071 |
| Cash From Investing Activities | 2.032 | -2.032 | -5.008 | -8 | |
| Capital Expenditures | 0 | 0 | 0 | ||
| Financing Cash Flow Items | |||||
| Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | ||
| Other Investing Cash Flow Items, Total | 2.032 | -2.032 | -5.008 | -8 |
| Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
|---|---|---|---|---|---|---|
| Armistice Capital LLC | Hedge Fund | 9.7013 | 982921 | 982921 | 2023-03-31 | HIGH |
| Bank of the West | Bank and Trust | 9.6232 | 975000 | 0 | 2022-12-31 | LOW |
| Najmabadi Family Trust | Corporation | 9.6232 | 975000 | 0 | 2023-04-15 | |
| Boston Scientific Corporation | Corporation | 5.3689 | 543971 | 0 | 2023-04-15 | LOW |
| Bagai (Shaun R.) | Individual Investor | 2.4828 | 251557 | 0 | 2023-04-15 | LOW |
| Nixon Peabody Financial Advisors LLC | Investment Advisor | 0.959 | 97165 | 0 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.4461 | 45193 | 34252 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4155 | 42100 | 5993 | 2023-03-31 | LOW |
| Marton (Laurence) | Individual Investor | 0.2511 | 25438 | 0 | 2023-04-15 | LOW |
| Cambridge Investment Research Advisors, Inc. | Investment Advisor | 0.1471 | 14900 | 500 | 2023-03-31 | LOW |
| Affinity Capital Advisors, LLC | Investment Advisor | 0.1311 | 13279 | -1980 | 2023-03-31 | LOW |
| Harbor Financial Services, LLC | Investment Advisor | 0.1096 | 11100 | 11100 | 2021-09-30 | |
| Kamran Najmabadi UEO | Individual Investor | 0.0987 | 10000 | 10000 | 2023-04-15 | |
| Agah (Ramtin M.D.) | Individual Investor | 0.0639 | 6477 | 0 | 2023-04-15 | |
| Tower Research Capital LLC | Hedge Fund | 0.0355 | 3601 | -515 | 2023-03-31 | HIGH |
| UBS Financial Services, Inc. | Investment Advisor | 0.025 | 2530 | 2530 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.008 | 814 | 814 | 2023-03-31 | LOW |
| Parametric Portfolio Associates LLC | Investment Advisor | 0.0017 | 176 | -152 | 2023-03-31 | LOW |
| Wells Fargo Bank, N.A. | Bank and Trust | 0.0004 | 42 | 1 | 2023-03-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
Kauplemise vahendustasu
0
- 1:1
Finantsvõimendus
1:1
- 20
- 100
- 500
- 1000
- 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind
Close
Lühike Pikk
RenovoRx, Inc. Company profile
Ettevõttest RenovoRx, Inc.
RenovoRx, Inc. on kliinilise faasi biofarmatseutiline ettevõte. Ettevõte keskendub ravimeetodite väljatöötamisele tahkete kasvajate kohalikuks raviks. Ettevõtte juhtiv tootekandidaat RenovoGem. Teiste tootekandidaatide hulka kuuluvad Renovo Trans-Arterial Micro-Perfusion (RenovoTAMP) ja RenovoCath manustamissüsteem. RenovoGem on ravimi ja seadme kombinatsioon, mis koosneb intraarteriaalsest gemtsitabiinist ja RenovoCathist. Tema raviplatvorm RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) keskendub ravimite kontsentratsiooni optimeerimisele tahketes kasvajates, kasutades väikemolekulaarseid keemiaravimeid, mis võimaldavad arstidel eraldada kasvajatele kõige lähemal olevad veresoonte anatoomia osad ja sundida keemiaravi läbi veresoonte seina, et need raskesti ligipääsetavad kasvajad keemiaraviga supelda.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
333 W Santa Clara St Ste 900
SAN JOSE
CALIFORNIA 95110
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com